Applications Published 22 November 2000
Published: 25-Jul-2001
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Compsns and methods for modulating cytokine releases in response to genotoxic agents
Applied Genetic Inc Dermatics 1052998*Chelated 8-hydroxyquinoline for the treatment of epithelial lesions
Dermex Pharmaceuticals 1052999*Agents and methods for protection, treatment and repair of connective tissue
Nutramax Laboratories 1053000*Novel mixed amylin activity compounds
Amylin Pharmaceuticals 1053001*Treatment of bony defects with osteoblast precursor cells.
Oregon Health Sciences Authority 1053002*Compsns and methods for separating lens epithelial cells and preventing posterior capsular opacification
Okada, Kiyoshi 1053003*Use of angiotensin analogues for promoting erythropoiesis
University of Southern California 1053004*Method of promoting keratinocyte proliferation
University of South Carolina 1053005*Costimulatory blockade and mixed chimerism in transplantation
The General Hospital Corp 1053006*Methods and compsns for modulating leptin activity
Beth Israel Deaconess Medical Centre 1053007*Methods of inducing hair growth and colouration
Trustees of Boston University 1053008*Use of heregulin as epithelial cell growth factor
Genentech; University of Iowa Research Foundation 1053009*Copolymer compsns for oral delivery
Supratek Pharma 1053010*Mixed micellar pharmaceutical delivery system and method of preparation
Generex Pharmaceuticals 1053011*Pharmaceutical compsns comprising PEG-asparaginase for the treatment of HIV infections
Aventis Pharmaceutical Products 1053012*Adenovirus vector containing a heterogeneous peptide epitope in the HI loop of the fibre knob
The UAB Research Foundation 1053013*Biologicaly active haemagglutinin from type A (Clostridium botulinum) and methods of use
University of Massachusetts 1053014*Pneumococcal and meningococcal vaccines formulated with Interleukin-12
American Cyanamid 1053015*Vaccines comprising Interleukin-12 and respiratory syncytial viral antigens
American Cyanamid 1053016*Vaccines comprising Interleukin-12 and herpes virus simplex viral antigen
American Cyanamid 1053017*Delivery of immunogenic molecules via HBSAG particles
Yissum Research Development Company of the Hebrew University of Jerusalem 1053018*Degradable heterobifunctional poly(ethylene glycol) acrylates and gels and conugates derived therefrom
Shearwater Polymers 1053019*Absorbable microparticles
Poly-Med 1053020*Simplified method for removing free protein during preparation of protein-polysaccharide conjugates and vaccines using restricted-access media
Henry M Jackson Foundation of the Advancement of Military Medicine 1053021*Sensitising cells to compounds using lipid-mediated gene and compound delivery
Inex Pharmaceuticals 1053022*Systemic delivery of serum stable plasmid lipid particles for cancer therapy
Inex Pharmaceuticals 1053023*Liposome fusion and delivery vehicle
Longmuir, Kenneth; Waring, Alan; Haynes, Sherry 1053024*Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery
The Regents of the University of California 1053025*Contrast medium based on polyoxethylene-660-12-hydroxystearate and anionic phospholipids
Gieselmann, Thomas 1053026*Bibapcitide-based pharmaceutical compsns for imaging and treating thrombi
Diatide 1053027*Sterile complex of a therapeutic peptide bond to a polysaccharide
Johnson & Johnson Medical 1053028*Diol compounds as intermediates for preparing antimycotic compounds
Zambon Group 1053218*Serine carbonates
Givaudan 1053223*Biphenylsulfonyl cyanamides, method for the production thereof and their utilisation as a medicament
Aventis Pharma 1053224*Process for the preparation of S-alkylcysteines
Zambon Group 1053225*Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
Novartis 1053226*Condensed 4-thioxopyrimidine derivatives as microbicides
Novartis 1053229*Triazine antiviral compounds
Scriptgen Pharmaceuticals 1053230*Process for the production of gamma-butyrolactone
Lonza 1053231*Process for the preparation of sotolon
Unilever 1053232*Hydroxamic acid and carboxylic acid derivatives
Darwin Discovery 1053233*Salts of paroxetine
SmithKline Beecham 1053234*Ozaxole derivatives as serotonin-1A receptor agonists
American Home Products 1053235*Pyridyl-bridgehead derivatives and their analogues, pharmaceutical compsns, and their use as inhibitors of nicotinic cholinergic receptors
RJ Reynolds Tobacco 1053236*Inhibition of human telomerase by a g-quadruplex-interaction compound
Board of Regents of the University of Texas System 1053237*Therapeutic compounds
Monash University 1053238*Glucocorticoid-selective anti-inflammatory agents
Abbott Laboratories 1053239*Novel dimerising agents, their production and use
President and Fellows of Harvard University 1053241*Dicarbamoyl-functionalised metal complexes
Targor 1053242*Sphingolipid derivatives and their methods of use
Emory University 1053243*45 secreted human proteins
Human Genome Sciences 1053245*Beta-sheet mimetics and methods relating to the use thereof
Molecumetics 1053246*Antifungal cyclohexapeptides
Fujisawa Pharmaceutical 1053247*Peptide structures and their use in diagnosis of herpes simplex virus type 2
Medical Research Council 1053248*Peptide inhibitors of the serine protease activity associated to the NS3 protein of HCV, relevant uses and the process of production
Istituto di Richerche di Biologia Molecolare P Angeletti 1053249*Modulation of sodium channels in dorsal root ganglia
Yale University 1053250*The Aiolos gene
General Hospital Corporation 1053251*Three-dimensional models and structures and models of FC receptors and uses thereof
Ilexus PTY 1053255*Antibodies to death receptor 4 (DR4) and uses thereof
Genentech 1053256*Carboxylated cellulose esters
Eastman Chemical 1053257*Device for producing polymer support materials in the form of porous polymer beads
Roehm 1053258*Metal triflimide complexes
The Research Foundation of the State University of New York 1053259*
